[{"address1": "2 Corporate Drive", "address2": "First Floor", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 239 2030", "website": "https://www.sentibio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Senti Biosciences, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. Its lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. The company's product candidates also include SENTI-202, a logic gated off-the-shelf CAR-NK cell therapy for the treatment of blood cancers and relapsed/refractory hematological malignancies, including acute myeloid leukemia; and SENTI-301A, an off-the-shelf CAR-NK cell therapy for the treatment of solid tumors and hepatocellular carcinoma. In addition, it develops the tumor-associated antigen and protective antigen paired discovery platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. Further, its pipeline includes preclinical programs, which comprise a solid tumor cell therapy program; and partnered programs related to gene therapies for tissue-directed targets, as well as partnered programs related to cell therapies for regenerative medicines. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 34, "companyOfficers": [{"maxAge": 1, "name": "Dr. Timothy K. Lu M.D., Ph.D.", "age": 43, "title": "Co-Founder, CEO & Director", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 630788, "exercisedValue": 0, "unexercisedValue": 261713}, {"maxAge": 1, "name": "Dr. Kanya  Rajangam M.D., Ph.D.", "age": 51, "title": "President, Head of Research & Development and Chief Medical Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 794047, "exercisedValue": 0, "unexercisedValue": 244533}, {"maxAge": 1, "name": "Dr. James J. Collins Ph.D.", "age": 58, "title": "Scientific Co-Founder, Chairperson of Scientific Advisory Board & Independent Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 43875, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Wilson  Wong Ph.D.", "title": "Scientific Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jay  Cross", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Faraz  Siddiqui", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert H. Cutler J.D.", "age": 56, "title": "Senior VP & Head of Legal Affairs", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas P. Chung", "title": "Vice President of Strategic Finance & Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Dee Olomajeye Dragon", "title": "VP of People & Culture Strategy & Head of Administrative Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.11, "open": 2.14, "dayLow": 2.14, "dayHigh": 2.25, "regularMarketPreviousClose": 2.11, "regularMarketOpen": 2.14, "regularMarketDayLow": 2.14, "regularMarketDayHigh": 2.25, "payoutRatio": 0.0, "beta": 2.101, "forwardPE": -2.9733334, "volume": 45087, "regularMarketVolume": 45087, "averageVolume": 181087, "averageVolume10days": 118080, "averageDailyVolume10Day": 118080, "bid": 2.2, "ask": 2.29, "bidSize": 1, "askSize": 1, "marketCap": 58628568, "fiftyTwoWeekLow": 1.26, "fiftyTwoWeekHigh": 16.94, "allTimeHigh": 105.4, "allTimeLow": 1.26, "fiftyDayAverage": 1.8326, "twoHundredDayAverage": 2.49263, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 75973568, "profitMargins": 0.0, "floatShares": 9706314, "sharesOutstanding": 26290838, "sharesShort": 177642, "sharesShortPriorMonth": 231302, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.0068, "heldPercentInsiders": 0.56751996, "heldPercentInstitutions": 0.22301, "shortRatio": 0.72, "shortPercentOfFloat": 0.0068, "impliedSharesOutstanding": 26290838, "bookValue": 0.309, "priceToBook": 7.216829, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -50103000, "trailingEps": -2.87, "forwardEps": -0.75, "lastSplitFactor": "1:10", "lastSplitDate": 1721260800, "enterpriseToEbitda": -1.352, "52WeekChange": -0.777, "SandP52WeekChange": 0.1326145, "quoteType": "EQUITY", "currentPrice": 2.23, "targetHighPrice": 15.0, "targetLowPrice": 6.0, "targetMeanPrice": 11.25, "targetMedianPrice": 12.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 12776000, "totalCashPerShare": 0.486, "ebitda": -56180000, "totalDebt": 30121000, "quickRatio": 1.207, "currentRatio": 1.51, "debtToEquity": 370.903, "returnOnAssets": -0.67774004, "returnOnEquity": -3.94617, "grossProfits": -37598000, "freeCashflow": -23475124, "operatingCashflow": -50073000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SNTI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 5.68721, "regularMarketPrice": 2.23, "shortName": "Senti Biosciences, Inc.", "longName": "Senti Biosciences, Inc.", "postMarketChangePercent": -2.4663706, "postMarketPrice": 2.175, "postMarketChange": -0.055000067, "regularMarketChange": 0.12, "regularMarketDayRange": "2.14 - 2.25", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 181087, "fiftyTwoWeekLowChange": 0.97, "fiftyTwoWeekLowChangePercent": 0.7698413, "fiftyTwoWeekRange": "1.26 - 16.94", "fiftyTwoWeekHighChange": -14.710001, "fiftyTwoWeekHighChangePercent": -0.86835897, "fiftyTwoWeekChangePercent": -77.700005, "earningsTimestampStart": 1755115260, "earningsTimestampEnd": 1755547260, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.87, "epsForward": -0.75, "epsCurrentYear": -2.65667, "priceEpsCurrentYear": -0.83939666, "fiftyDayAverageChange": 0.39740002, "fiftyDayAverageChangePercent": 0.21685039, "twoHundredDayAverageChange": -0.26263, "twoHundredDayAverageChangePercent": -0.1053626, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1764367094, "regularMarketTime": 1764352800, "exchange": "NCM", "messageBoardId": "finmb_538838857", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1622035800000, "displayName": "Senti Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]